Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, et al. Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer. Clin Cancer Res 2023 May 15:CCR-23-0112. doi: 10.1158/1078-0432.CCR-23-0112.
PMID: 37184422